MedicaidBilling CodesMedium impact
Healthcare Common Procedure Coding System (HCPCS) Code A9607 Must Be Billed With a National Drug Code
Nevada Medicaid·NV · Oncology, Nuclear Medicine·Pharmacy
Effective date
Dec 8, 2025
We identified it
Jun 21, 2026
Summary
Effective December 8, 2025, Nevada Medicaid requires that HCPCS code A9607 (Lutetium Lu 177 Vipivotide) must be billed with a National Drug Code (NDC) on physician-administered drug claims. This is a new billing requirement for this specific radiopharmaceutical used in oncology treatments.
Action Required
By December 8, 2025: Billing team must update Nevada Medicaid claims processing to include NDC numbers when billing HCPCS code A9607 (Lutetium Lu 177 Vipivotide) on physician-administered drug claims. Verify billing system can capture and transmit NDC data for this code. Claims without NDC will likely be rejected.